Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Personal Genome Machine (PGM™) Sequencer

Product Image
Product Description

The Personal Genome Machine (PGM™) Sequencer is a benchtop PostLight™ semiconductor-based platform that performs a sequencing run in approximately two hours. With a small benchtop footprint and a weight of 65 lbs (~30kg), low cost sequencing reagents, and simple touchscreen user interface, the Personal Genome Machine (PGM™) Sequencer brings next generation sequencing to every lab. The PGM™ Sequencer requires a Torrent Server for operation. The PGM™ includes a one year warranty on parts, labor, and travel for service personnel. A field service installation plan for the Personal Genome Machine System maximizes your productivity with installation of the Personal Genome Machine™ System by one of our certified field service engineers.

Features of the Personal Genome Machine™ Sequencing Platform Include:

• Scalable (1000x) semiconductor technology
• Natural biochemistry using inexpensive reagents
• Compatibility with all current library preparation methods
• Sequencing run times of about 2 hours
• A straightforward touchscreen user interface

The Personal Genome Machine™ advances Next-Generation sequencing to PostLight™ sequencing—the translation of chemical sequence information directly into digital form. PostLight™ technology means genetic sequencing is leveraged by the extreme scalability of semiconductor technology. Moore’s law is applied to genetic analysis.

Affordable Sequencing For Nearly Every Lab

Previous sequencing technologies have relied upon optical systems as bridges between the chemical and digital forms of sequence information. These systems have added tremendous costs to sequencers, relegating them to only the largest laboratories. By eliminating the need for the optical system, the Personal Genome Machine™ provides sequencing that is simpler, faster, more cost effective, and more scalable than any other technology available. With a small benchtop footprint and weight of 65 lbs (~30kg), low cost sequencing reagents, and a simple.

Product Personal Genome Machine (PGM™) Sequencer
Company Life Technologies
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Life Technologies
3175 Staley Road Grand Island, NY 14072 USA

Tel: +1.800.955.6288
Fax: +1.800.331.2286
Email: catalog@lifetech.com



Scientific News
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!